The aim of this study was to assess the accuracy of the Convolution Kernel Compensation (CKC) method in decomposing high-definition surface EMG (HDsEMG) signals from the pennate biceps femoris long-head muscle. Although the CKC method has already been thoroughly assessed in parallel-fibered muscles, there are several factors that could hinder its performance in pennate muscles. Namely, HDsEMG signals from pennate and parallel-fibered muscles differ considerably in terms of the number of detectable motor units (MUs) and the spatial distribution of the motor-unit action potentials (MUAPs). In this study, monopolar surface EMG signals were recorded from 5 normal subjects during low-force voluntary isometric contractions using a 92-channel electrode grid with 8 mm inter-electrode distances. Intramuscular EMG (iEMG) signals were recorded concurrently using monopolar needles. The HDsEMG and iEMG signals were independently decomposed into MUAP trains, and the iEMG results were verified using a rigorous a-posteriori statistical analysis. HDsEMG decomposition identified from 2 to 30 MUAP trains per contraction. 3±2 of these trains were also reliably detected by iEMG decomposition. The measured CKC decomposition accuracy of these common trains over a selected 10 second interval was 91.5±5.8 %. The other trains were not assessed. The significant factors that affected CKC decomposition accuracy were the number of HDsEMG channels that were free of technical artifact and the distinguishability of the MUAPs in the HDsEMG signal (P<0.05). These results show that the CKC method reliably identifies at least a subset of MUAP trains in HDsEMG signals from low force contractions in pennate muscles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.